Dublin, June 21, 2018 (GLOBE NEWSWIRE) -- The "Global Cell Free DNA Isolation and Extraction Market - Focus on 25 Country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform - Analysis and Forecast, 2018-2026" report has been added to ResearchAndMarkets.com's offering.
The global cell free DNA isolation and extraction market is anticipated to grow over $442.8 Million with 14,638.3 Thousand units by 2026, aided by the rising demand for non-invasive prenatal testing among high risk pregnant women and increased demand for liquid biopsy.
North America is the leading contributor to the global cell free DNA isolation and extraction market, in terms of both, volume and revenue. The contribution of North America to the global cell free DNA isolation and extraction market was volume and valued to be approximately 59% and 61% in 2016, respectively.
However, Asia Pacific is expected to grow, by volume, at an impressive 21.15% CAGR during the forecast period. The extraction kits hold the largest share of the total cfDNA extraction/isolation market and growing at a double digit CAGR. Furthermore, with magnetic bead-based kits, proteinase and heat treatment are unnecessary, enabling all the processes to be conducted at room temperature. As compared to traditional cfDNA extraction methods, there is also a significant reduction in processing and hands-on time. Among the applications, non-invasive prenatal testing (NIPT) leads the cfDNA extraction/isolation market share. In 2016, the NIPT segment accounted for 72% of the total market. However, the market share of NIPT segment is expected to decrease substantially during the forecast period owing high market penetration rate of cfDNA technology in the cancer diagnostic and screening application. In 2016, next generation sequencing was the most used downstream quantification technique for cfDNA and accounted for 71% of the total sample processing share and is expected to remain the leading quantification technique in 2026. This market intelligence report provides a multidimensional view of the global cell free DNA isolation and extraction market in terms of market size and growth potential. This research report aims at answering various aspects of the global cell free DNA isolation and extraction market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions, among others. The research report provides a comprehensive analysis of the product sales, and manufacturers, and trend analysis by segments and demand analysis by geographical regions. The answers to the following key questions can be derived from this report:
- What are the major market drivers, challenges and opportunities in the Cell-free DNA testing market?
- What was the market value of the leading segments and sub-segments of the global Cell-free DNA testing in 2016?
- How will each segment of the global Cell-free DNA testing market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2026?
- What are the influencing factors that may affect the market share of the key players in Cell-free DNA testing market?
- How will the Cell-free DNA testing industry evolve during the forecast period 2018- 2026?
- What are the key developmental strategies that are being implemented by the key players to sustain in this market?
- What is the market share of each of the companies by NIPT test providers?
- What is the growth-share matrix of each of the companies by NIPT test providers?
- Who are the key players in the Cell-free DNA extraction/isolation kits market and what are their contributions?
- What are the major benefits of the implementation of Cell-free DNA testing in the different field of applications including cancer diagnosis, prenatal testing, and several other chronic diseases?
- What is the scope of Cell-free DNA testing in the emerging economies of the Asia Pacific and Latin America?
- What is the scope for expansion by the key players of the Cell-free DNA testing market in the Asia Pacific and Latin America?
Key Topics Covered:
Executive Summary
1 Market Overview 1.1 Introduction 1.2 Early Discovery and Applications of cfDNA 1.3 Properties of cfDNA 1.4 Biological Role of cfDNA 1.5 Extraction of Circulating cfDNA 1.6 Application of Circulating cfDNA 1.7 Addressable Market Size and Growth Potential 1.8 Recent Historical Trends 2013-2016 (Parent Market: Genomics) 1.9 Recent Historical Trends 2013-2016 (cfDNA)
2 Market Dynamics 2.1 Promoting and Inhibiting Factors of cfDNA Market Growth 2.2 Market Drivers 2.3 Market Restraints 2.4 Market Opportunities
3 Competitive Landscape 3.1 Key Develoments and Stratgies 3.2 Market Share Analysis by Company (2015 and 2016) 3.3 Value Chain Analysis
4 Pricing Analysis 4.1 cfDNA Extraction Kits Pricing Analysis
5 Global Cell Free DNA Extraction and Isolation Market, by Product 5.1 Analysis 5.2 Cell Free DNA Extraction and Isolation Kits 5.3 Cell Free DNA Automated Instruments 5.4 Consumables
6 Global Cell Free DNA Extraction and Isolation Market, by Platform 6.1 Introduction 6.2 Next Generation Sequencing 6.3 Polymerase Chain Reaction (PCR) 6.4 Others
7 Global Cell Free DNA Extraction and Isolation Market, by Applications 7.1 Overview 7.2 Non-Invasive Prenatal Testing (NIPT) 7.3 Oncology 7.4 Transplant Rejection and Other Disease Condition 7.5 Others
8 Global Cell Free DNA Extraction and Isolation Market, by Region
9 Company Profiles 9.1 Overview 9.2 Agilent Technologies, Inc. 9.3 AccuBioMed 9.4 Aline Biosciences 9.5 Berry Genomics 9.6 BioChain 9.7 Bioo Scientific Corporation 9.8 BGI Diagnostics 9.9 BioCAT GmbH 9.1 Epigentek Group Inc. 9.11 F. Hoffmann-La Roche AG 9.12 GATC Biotech AG. 9.13 Illumina, Inc. 9.14 Laboratory Corporation of America 9.15 LifeCodexx AG 9.16 Merck KGaA 9.17 Natera Inc. 9.18 NIPD Genetics 9.19 Norgen Biotek Corp 9.2 PreAnalytiX GmbH 9.21 Premaitha Health Plc 9.22 GATC Biotech AG. 9.23 Illumina, Inc. 9.24 Laboratory Corporation of America 9.25 QIAGEN 9.26 Quest Diagnostics 9.27 SeraCare Life Sciences, Inc. 9.28 STRATEC Biomedical AG 9.29 Thermo Fisher Scientific 9.3 NeoGenStar LLC 9.31 Omega Bio-tek, Inc 9.32 Promega Corporation 9.33 System Biosciences, LLC. 9.34 STRECK, INC.
10 Report Scope & Methodology
For more information about this report visit https://www.researchandmarkets.com/research/t..._free?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Genomics, Molecular Diagnostics
